• Semma names former Novartis, Magenta executive as new CEO fiercebiotech
    May 16, 2018
    Regenerative medicine developer Semma Therapeutics is bringing on Bastiano Sanna, formerly of Novartis’ cell and gene therapy unit and Magenta Therapeutics, to serve as its president and CEO following a $114 million funding round late last year.
PharmaSources Customer Service